Results 21 to 30 of about 13,945 (154)
Smart Biomaterials and Dressings for the Treatment of Chronic Inflammatory Skin Diseases
Rare Metals, Volume 45, Issue 2, February 2026.ABSTRACT Chronic inflammatory skin diseases, encompassing immune‐inflammatory conditions and infection‐associated dermatoses, pose significant clinical challenges due to high prevalence, recurrence, and therapeutic resistance, affect over 30% of the global population.
Zehao Lan +5 more
wiley +1 more source
Veterinary Dermatology, Volume 37, Issue 1, Page 140-147, February 2026.Background: Normal hydration of the canine epidermis is imperative for cutaneous homeostasis. Xerosis may be encountered in canine atopic dermatitis and may be aggravated by topical antiseptics. Hypothesis and Objectives: To evaluate the hydrating properties and the safety of a spray (Sensiderm spray; MP Labo) when applied after shampooing healthy dogs
Adamantia Pseftogka +3 more
wiley +1 more source
Ultrasound in Obstetrics &Gynecology, Volume 66, Issue 6, Page 706-715, December 2025.ABSTRACT Objective To evaluate the use of twin vs singleton growth charts for detecting small‐for‐gestational‐age (SGA) twins at risk of adverse neonatal outcomes. Methods MEDLINE, EMBASE, CINAHL, Cochrane and Scopus databases were searched electronically from inception to May 2024.
S. Sorrenti +9 more
wiley +1 more source
Hydrocortisone Aceponate for Chronic Otitis: Long‐Term Efficacy
Veterinary Dermatology, Volume 36, Issue 6, Page 870-878, December 2025.Effective management of otitis externa (OE) requires addressing all contributing factors to prevent chronicity and recurrence. Evidence on the long‐term efficacy of topical corticosteroids in preventing recurrence and secondary infections remains limited. This retrospective noncontrolled study evaluated the efficacy of hydrocortisone aceponate (HCA) in
C. Lorente‐Méndez, D. Alonso‐Miguel
wiley +1 more source
Veterinary Dermatology, Volume 36, Issue 4, Page 453-461, August 2025.Background – Canine atopic dermatitis (cAD) is a chronic, inflammatory, multifactorial and pruritic disease. The presence of skin barrier impairment (e.g. filaggrin alterations), along with abnormal immune responses, can negatively impact cutaneous barrier function.
Wendie Roldan Villalobos +5 more
wiley +1 more source
N-Oleoylethanolamine attenuates cytokines and adhesion molecules production in TNF-α-induced human umbilical vein endothelial cells by activating PPAR-α and CB2 [PDF]
, 2015 研究背景：动脉粥样硬化（Atherosclerosis,As）是由多个因素造成的开始于动脉内膜的一种疾病，现如今As的发病率和致死率逐渐升高，并且发病年龄年轻化。大量的流行病学调查和实验研究证明,高血脂、高血压、吸烟、糖尿病等都是与As发生相关的危险因素，但关于As发生的机制一直众说纷纭，直到1999年，ROSS等提出“As是一种慢性炎症性疾病”的观点，给As的研究带来了一个全新的方向与思路。本论文的研究就是基于这个观点，从炎症反应的角度去探索一种新的、副作用小的抗动脉粥样硬化药物。油酰乙醇胺（N ...
许旭东
core
Veterinary Dermatology, Volume 36, Issue 2, Page 165-176, April 2025.Background – Janus kinase inhibitors (JAKi) have been shown to reduce pruritus and improve associated inflammatory skin lesions in canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, in comparison to oclacitinib, for the control of cAD in a randomised, blinded trial.
Sophie Forster +4 more
wiley +1 more source
Linchuang shenzangbing zazhi, 2013 目的 探讨维持性血液透析(MHD)患者热休克蛋白70(HSP70)检测与炎症状态的关系。方法 将MHD患者92例根据超敏C反应蛋白(hs-CRP)水平分为2组:非炎症组(hs ...
刘琨
doaj
The relationship between the levels of white blood cell and lipopolysaccharide binding protein and intrahepatic triglyceride content , metabolic abnormalities in obese adults [PDF]
, 2016 研究目的 非酒精性脂肪性肝病（NAFLD）常常伴随炎性因子的增多，且其发生发展与代谢综合征和胰岛素抵抗紧密相关。本研究针对中心性肥胖人群进行横断面数据分析，探讨白细胞（WBC）及脂多糖结合蛋白水平（LBP）与肝脏脂质含量（IHTC）及其相关代谢异常的关系。 研究方法 本研究纳入485名40-65岁中心性肥胖受试者，进行问卷调查包括病史、生活方式等；测定生化指标并进行胰岛功能评估；通过氢质子磁共振波谱（1H-MRS）技术定量分析肝内甘油三酯含量；进行内脏脂肪含量等测定 ...
孙倩
core
Long‐term use of lokivetmab in dogs with atopic dermatitis
Veterinary Dermatology, Volume 35, Issue 6, Page 683-693, December 2024.Background – Lokivetmab, a caninised monoclonal antibody against interleukin (IL)‐31, is an effective treatment for the pruritus associated with canine atopic dermatitis (cAD). Objectives – To investigate the efficacy and safety of lokivetmab during long‐term treatment defined as at least three consecutive lokivetmab injections in atopic dogs under ...
Bettina Kasper +2 more
wiley +1 more source